Cas:40019-65-6 2-(2-chlorobenzimidazol-1-yl)ethanol manufacturer & supplier

We serve Chemical Name:2-(2-chlorobenzimidazol-1-yl)ethanol CAS:40019-65-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(2-chlorobenzimidazol-1-yl)ethanol

Chemical Name:2-(2-chlorobenzimidazol-1-yl)ethanol
CAS.NO:40019-65-6
Synonyms:f1725-0057
Molecular Formula:C9H9ClN2O
Molecular Weight:196.63400
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:389ºC at 760 mmHg
Density:1.37g/cm3
Index of Refraction:1.64
PSA:38.05000
Exact Mass:196.04000
LogP:1.68200

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2811 6.1 / PGIII
Packing Group:


Contact us for information like f1725-0057 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,f1725-0057 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,f1725-0057 Use and application,f1725-0057 technical grade,usp/ep/jp grade.


Related News: In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market. 2-(2-chlorobenzimidazol-1-yl)ethanol manufacturer Catalent, a global leader in clinical supply services, recently announced the launch of its new CTSuccessTM clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress. 2-(2-chlorobenzimidazol-1-yl)ethanol supplier Catalent, a global leader in clinical supply services, recently announced the launch of its new CTSuccessTM clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress. 2-(2-chlorobenzimidazol-1-yl)ethanol vendor There are also new directives that relate to US citizens. 2-(2-chlorobenzimidazol-1-yl)ethanol factory Further research on Oligomannate��s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement.